4//SEC Filing
Gamelin John 4
Accession 0001449374-19-000019
CIK 0000764579other
Filed
Apr 21, 8:00 PM ET
Accepted
Apr 22, 10:45 AM ET
Size
19.8 KB
Accession
0001449374-19-000019
Insider Transaction Report
Form 4
Gamelin John
Vice President - R & D
Transactions
- Disposition to Issuer
Stock Option
2019-04-18−20,000→ 0 totalExercise: $0.67Exp: 2027-12-21→ Common Stock (20,000 underlying) - Disposition to Issuer
Common Stock
2019-04-18$2.45/sh−186,078$455,891→ 0 total - Disposition to Issuer
Stock Option
2019-04-18−56,000→ 0 totalExercise: $1.69Exp: 2021-12-08→ Common Stock (56,000 underlying) - Disposition to Issuer
Stock Option
2019-04-18−40,000→ 0 totalExercise: $1.87Exp: 2023-12-16→ Common Stock (40,000 underlying) - Disposition to Issuer
Stock Option
2019-04-18−60,000→ 0 totalExercise: $2.18Exp: 2022-12-17→ Common Stock (60,000 underlying) - Disposition to Issuer
Stock Option
2019-04-18−40,000→ 0 totalExercise: $1.79Exp: 2024-12-18→ Common Stock (40,000 underlying) - Disposition to Issuer
Stock Option
2019-04-18−44,000→ 0 totalExercise: $3.00Exp: 2020-11-19→ Common Stock (44,000 underlying)
Footnotes (7)
- [F1]Each issued and outstanding share of common stock was, as a result of the consummation of the merger contemplated by the Agreement and Merger by and among CAS Medical Systems, Inc., Edwards Lifesciences Holding, Inc. and Crown Merger Sub, Inc., dated as of February 11, 2019 (the "Merger Agreement"), canceled in exchange for the right to receive a per share amount equal to $2.45 in cash without interest.
- [F2]This option, was, as a result of the consummation of the merger contemplated by the Merger Agreement, terminated on April 18, 2019.
- [F3]This option, which vested in four equal annual installments commencing on December 8, 2011, was, as a result of the consummation of the merger contemplated by the Merger Agreement, canceled in exchange for a cash payment equal to the product of the number of shares subject to such option multiplied by the excess of $2.45 over the exercise price per share of such option.
- [F4]This option, which vested in four equal annual installments commencing on December 17, 2012, was, as a result of the consummation of the merger contemplated by the Merger Agreement, canceled in exchange for a cash payment equal to the product of the number of shares subject to such option multiplied by the excess of $2.45 over the exercise price per share of such option.
- [F5]This option, which vested in four equal annual installments commencing on December 16, 2014, was, as a result of the consummation of the merger contemplated by the Merger Agreement, canceled in exchange for a cash payment equal to the product of the number of shares subject to such option multiplied by the excess of $2.45 over the exercise price per share of such option.
- [F6]This option, which vested in four equal annual installments commencing on December 18, 2015, was, as a result of the consummation of the merger contemplated by the Merger Agreement, canceled in exchange for a cash payment equal to the product of the number of shares subject to such option multiplied by the excess of $2.45 over the exercise price per share of such option.
- [F7]This option, which vested in four equal annual installments commencing on December 21, 2018, was, as a result of the consummation of the merger contemplated by the Merger Agreement, canceled in exchange for a cash payment equal to the product of the number of shares subject to such option multiplied by the excess of $2.45 over the exercise price per share of such option.
Documents
Issuer
CAS MEDICAL SYSTEMS INC
CIK 0000764579
Entity typeother
Related Parties
1- filerCIK 0001563590
Filing Metadata
- Form type
- 4
- Filed
- Apr 21, 8:00 PM ET
- Accepted
- Apr 22, 10:45 AM ET
- Size
- 19.8 KB